Patent application number | Description | Published |
20080254507 | Anti-Hiv Drug, Polypeptide Constituting the Same, Gene Encoding the Polypeptide and Method of Producing the Anti-Hiv Drug - It is intended to provide an anti-HIV drug characterized by containing multimeric actinohivin, a polypeptide which is multimeric actinohivin; a gene encoding the same; and a method of producing the anti-HIV drug. The anti-HIV drug inhibits the synctium formation and has an enhanced effect | 10-16-2008 |
20090093646 | NOVEL COMPOUND OF STEMPHONES AND PRODUCTION THEREOF - The present invention relates to novel compound of stemphones obtained by culturing microorganism belonging to genus | 04-09-2009 |
20090130717 | Novel K04-0144 Substance and a Process for Production Thereof - A microorganism represented by a strain K04-0144 belonging to | 05-21-2009 |
20090131341 | Novel Dihydropseudoerythromycin Derivatives - A compound represented by the formula [I] wherein each symbol is as defined in the specification or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing the compound as an active ingredient. | 05-21-2009 |
20110021848 | WICKEROL AND METHOD FOR PRODUCING THE SAME - The present invention includes wickerol and a method for producing the wickerol. In the method for producing the wickerol, | 01-27-2011 |
20110105769 | Novel Substance FKI-3864 and Method for Preparation Thereof - This invention relates to substance FKI-3864 represented by the following formula [I] having an inhibitory activity on the synthesis of triacylglycerols and a method for preparing the same. The substance FKI-3864 can be prepared by a method comprising culturing a microorganism which belongs to the genus | 05-05-2011 |
20110184173 | Pyripyropene Derivatives Having An ACAT2-Inhibiting Activity - The present invention is a compound having the general formula (I), (II), or (III) or a pharmacologically acceptable salt, solvate, or hydrate thereof, and a pharmaceutical composition containing such a compound, or its pharmacologically acceptable ester, or other pharmacologically acceptable derivative thereof as an active ingredient. The compound has an excellent ACAT 2-inhibiting activity by a mechanism different from that of a statin drug and is useful as a therapeutic or prophylactic agent for obesity, adiposis, hyperlipidemia, hypercholesterolemia, disorder of lipid metabolism, and arteriosclerosis, as well as obesity-derived hyperlipidemia, hypercholesterolemia, disorder of lipid metabolism, arteriosclerosis, and hypertension. | 07-28-2011 |
20140206889 | NOVEL MANGROMICIN COMPOUND AND PRODUCTION METHOD THEREFOR | 07-24-2014 |
20140349954 | ANTIBACTERIAL TYLOSIN DERIVATIVES AND METHODS FOR THEIR PREPARATION - The present invention relates to new macrolide derivatives, in particular new tylosin derivatives of the formula (I); a pharmaceutical or veterinary composition comprising the derivatives; a method for preparation thereof; a method for treating and/or preventing bacterial infections in an animal, wherein the method comprises administering the derivatives or the composition; and a use of the derivatives for the manufacture of medicaments for treating and/or preventing bacterial infections in an animal. | 11-27-2014 |